


Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
¥
₽
€
$
¥
NT$
₫
aed
₴
zł
R$
Rp
$
₼Ethereum developers are narrowing several proposals spanning privacy and MEV economics for the upcoming Hegota upgrade.
Peter Todd reignites discussions on tail emission, a proposal that would eliminate the limit of 21 million units of Bitcoin.
Goldman Sachs warns that U.S. consumer spending will slow down in the second half of 2026, following a temporary boost from tax refunds. The bank expects real spending growth to fall to 1-1.5% and raises doubts about the resilience of consumption, with implications for retailers and markets.